Abstract
Bone marrow histology after bone marrow transplantation has rarely been studied. Here, we reviewed the pre- and post-transplant bone marrow biopsies (BMB) of 40 acute myelogenous leukemia (AML) patients autografted in our center, 28 with normal and 12 with delayed peripheral recovery. The two groups were comparable in terms of previous therapy, disease phase and the number of infused cells, and received the same conditioning regimen. In the former group, reduced bone marrow cellularity and mild reticulin abnormalities were usual histological findings; in the latter, five patients had the same pattern, but the other seven had an almost undetectable hematopoietic parenchyma and severe reticulin derangement. One of these seven patients died of reactivated hepatitis B virus infection; the others eventually achieved peripheral recovery, with none of them experiencing a relapse. Autografted AML patients are excellent subjects for histological investigations. They account for the majority of delayed engraftments, the contribution of extramedullary components to the timing of engraftment is minimal, and leukemia relapse cannot be ruled out. These results suggest that BMB is a useful investigation in the work-up of late engraftment. A high degree of reticulin derangement with an almost undetectable hematopoietic parenchyma appear to be the morphological hallmarks of late engraftment. Bone Marrow Transplantation (2000) 25, 837–841.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ippoliti C, Przepiorka D, Giralt S et al. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation Bone Marrow Transplant 1993 11: 55–59
Crump M, Couture F, Kovacs M et al. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation Exp Hematol 1993 21: 405–410
Khwaja A, Goldstone AH, Linch DC . Delayed neutrophil recovery after BEAM chemotherapy and autologous bone marrow transplantation for lymphoma is not associated with increased mortality from infection Bone Marrow Transplant 1995 15: 313–315
Rajantie J, Sale GE, Deeg HJ et al. Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation Blood 1986 67: 1693–1697
Lazarus HM, Chahine A, Lacerna K et al. Kinetics of erythrogenesis after bone marrow transplantation Am J Clin Pathol 1992 97: 574–583
Hirao A, Kawano Y, Takaue Y et al. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system Exp Hematol 1994 22: 521–526
Deeg HJ, Beckham C, Huss R et al. Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand Blood 1994 83: 2352–2359
Enright H, Haake R, Weisdorf D . Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation Am J Med 1990 89: 733–738
Verdonck LF, de Gast GC, van Heutgen HG et al. Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation Blood 1991 78: 844–848
Beguin Y, Oris R, Fillet G . Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous vs allogeneic transplants Bone Marrow Transplant 1993 11: 285–292
Brandwein JM, Nayar R, Baker MA et al. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation Exp Hematol 1991 19: 191–195
Haas R, Witt B, Möhle R et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support Blood 1995 85: 3754–3761
Vey N, Molnar S, Faucher C et al. Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery Bone Marrow Transplant 1994 14: 779–782
Vose JM, Bierman PJ, Kessinger A et al. The use of recombinant human granulocyte–macrophage colony-stimulating factor for the treatment of delayed engraftment following high-dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies Bone Marrow Transplant 1991 7: 139–143
Pendry K, Alcorn MJ, Burnett AK . Factors influencing haematological recovery in 53 patients with acute myeloid leukaemia in first remission after autologous bone marrow transplantation Br J Haematol 1993 83: 45–52
Tiedemann K, Waters KD, Tauro GP et al. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission Blood 1993 82: 3730–3738
Robertson MJ, Soiffer RJ, Freedman AS et al. Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia Blood 1992 79: 2229–2236
Lenarsky C, Weinberg K, Petersen J et al. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission Bone Marrow Transplant 1990 6: 425–429
Jackson GH, Clarke AJ, Taylor P et al. Supernatant cell counts from long-term bone marrow cultures correlate with the speed of engraftment following autologous bone marrow transplantation Bone Marrow Transplant 1991 8: 439–444
Straetmans N, Ma DDF, Herman Ph et al. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment Bone Marrow Transplant 1995 15: 421–428
Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients Blood 1995 85: 588–596
Domenech J, Roingeard F, Binet C . The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation Leuk Lymphoma 1997 24: 239–256
Rosenthal NS, Farhi DC . Failure to engraft after bone marrow transplantation: bone marrow morphologic findings Am J Clin Pathol 1994 102: 821–824
Wilson PA, Ayscue LH, Jones GR, Bentley SA . Bone marrow histiocytic proliferation in association with colony-stimulating factor therapy Am J Clin Pathol 1993 99: 311–313
Bierkens JG, Hendry JH, Testa NG . The radiation response and recovery of bone marrow stroma with particular reference to long-term bone marrow cultures Eur J Haematol 1989 43: 95–107
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Annaloro, C., Oriani, A., Pozzoli, E. et al. Histological alterations in bone marrow in patients with late engraftment after autologous bone marrow transplantation. Bone Marrow Transplant 25, 837–841 (2000). https://doi.org/10.1038/sj.bmt.1702241
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702241